Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abcam
Cambridge, England, United Kingdomabcam.com ↗
- Ownership
- Public · ABCM
- Employees
- ~1450
- Development stage
- Other
01
Overview
Abcam does not develop therapeutics but provides highly validated antibodies and reagents that support drug discovery and diagnostics globally. Their products are widely cited in scientific literature and used by over 750,000 researchers worldwide
- Therapeutic areas
- Other
- Modalities
- AntibodyRecombinant proteinPeptidesCell line
- Industry
- Chemicals & Materials
02
Partnerships
Collaborates with life science organizations for co-development of antibodies as key reagents in drug discovery and diagnostics.Partners include over 400 suppliers globally for sourcing additional products
Beyond the preview
Go deeper on Abcam.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Abcam.